237 related articles for article (PubMed ID: 21309180)
1. [Pediatrics. Fecal calprotectin in children: use and interpretation].
Ezri J; Nydegger A
Rev Med Suisse; 2011 Jan; 7(277):69-70. PubMed ID: 21309180
[TBL] [Abstract][Full Text] [Related]
2. The use of fecal calprotectin as a biomarker in gastrointestinal disease.
Burri E; Beglinger C
Expert Rev Gastroenterol Hepatol; 2014 Feb; 8(2):197-210. PubMed ID: 24345070
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
Kolho KL; Raivio T; Lindahl H; Savilahti E
Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice.
Berni Canani R; Rapacciuolo L; Romano MT; Tanturri de Horatio L; Terrin G; Manguso F; Cirillo P; Paparo F; Troncone R
Dig Liver Dis; 2004 Jul; 36(7):467-70. PubMed ID: 15285526
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
6. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
van den Bergh FA; Kolkman JJ; Russel MG; Vlaskamp RT; Vermes I
Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2360-5. PubMed ID: 14677476
[TBL] [Abstract][Full Text] [Related]
7. Fecal calprotectin in very low birth weight infants.
Josefsson S; Bunn SK; Domellöf M
J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):407-13. PubMed ID: 17414135
[TBL] [Abstract][Full Text] [Related]
8. Fecal markers: calprotectin and lactoferrin.
Abraham BP; Kane S
Gastroenterol Clin North Am; 2012 Jun; 41(2):483-95. PubMed ID: 22500530
[TBL] [Abstract][Full Text] [Related]
9. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.
Reinders CA; Jonkers D; Janson EA; Stockbrügger RW; Stobberingh EE; Hellström PM; Lundberg JO
Scand J Gastroenterol; 2007 Oct; 42(10):1151-7. PubMed ID: 17852876
[TBL] [Abstract][Full Text] [Related]
10. [Faecal calprotectin in inflammatory bowel disease].
Sipponen T; Kolho KL
Duodecim; 2011; 127(24):2631-7. PubMed ID: 22320105
[TBL] [Abstract][Full Text] [Related]
11. Fecal calprotectin (FC) in newborns: is it a predictive marker of gastrointestinal and/or allergic disease?
Baldassarre ME; Fanelli M; Lasorella ML; Laneve A; Grosso R; Falcone MR; Laforgia N
Immunopharmacol Immunotoxicol; 2011 Mar; 33(1):220-3. PubMed ID: 20602542
[TBL] [Abstract][Full Text] [Related]
12. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children.
Chen CC; Huang JL; Chang CJ; Kong MS
J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):541-7. PubMed ID: 22699836
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of calprotectin level in intestinal content as an early marker for graft rejection.
Cagnola H; Scaravonati R; Cabanne A; Bianchi C; Gruz F; Errea A; Zambernardi A; Meier D; Chirdo F; Docena G; Gondolesi G; Rumbo M
Transplant Proc; 2010; 42(1):57-61. PubMed ID: 20172281
[TBL] [Abstract][Full Text] [Related]
14. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
[TBL] [Abstract][Full Text] [Related]
15. Calprotectin in ankylosing spondylitis--frequently elevated in feces, but normal in serum.
Klingberg E; Carlsten H; Hilme E; Hedberg M; Forsblad-d'Elia H
Scand J Gastroenterol; 2012 Apr; 47(4):435-44. PubMed ID: 22229862
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy.
von Roon AC; Karamountzos L; Purkayastha S; Reese GE; Darzi AW; Teare JP; Paraskeva P; Tekkis PP
Am J Gastroenterol; 2007 Apr; 102(4):803-13. PubMed ID: 17324124
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
Fagerberg UL; Lööf L; Lindholm J; Hansson LO; Finkel Y
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):414-20. PubMed ID: 18030206
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
Kallel L; Ayadi I; Matri S; Fekih M; Mahmoud NB; Feki M; Karoui S; Zouari B; Boubaker J; Kaabachi N; Filali A
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):340-5. PubMed ID: 19581809
[TBL] [Abstract][Full Text] [Related]
19. [Measurement of calprotectin in faeces].
Jahnsen J; Røseth AG; Aadland E
Tidsskr Nor Laegeforen; 2009 Apr; 129(8):743-5. PubMed ID: 19373299
[TBL] [Abstract][Full Text] [Related]
20. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.
Caviglia GP; Pantaleoni S; Touscoz GA; Adriani A; Rosso C; Smedile A; Pellicano R; Astegiano M; Bresso F
Scand J Gastroenterol; 2014 Dec; 49(12):1419-24. PubMed ID: 25369978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
